Moderna Stock News

OTTAWA - Health Canada says it has received a submission from Moderna to authorize use of its COVID-19 vaccine for children aged six to 11. The agency

Moderna is asking Health Canada to approve its COVID-19 vaccine for children aged six to 11.

(RTTNews) - Moderna, Inc. (MRNA) announced an agreement that enables the European Union and European Economic Area countries to donate doses of the Moderna COVID-19 vaccine to COVAX on an ongoing basis for delivery in 2021. The donations of Moderna vaccine to COVAX will be directed to the 92 Gavi COVAX Advance Market Commitment low- and

The Peoples Vaccine Alliance (PVA) has carried out an analysis on Pfizer, BioNTech and Moderna which suggests that the three drugmakers are making as much as $65,000 as combined profit every minute. This conclusion was based on calculations of the firms own earning reports by PVA. The profit is generated from their highly successful COVID-19 []

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement that enables the European Union (EU) and European Econ

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement that enables the European Union (EU) and European Economic Area (EEA) countries to donate doses of the Moderna COVID-19 vaccine that they have purchased under the EU Vaccines Strategy to COVAX on an ongoing basis for delivery in 2021. This initiative, led

The procedure for the administration of a booster dose for individuals aged 40 years and over starts as of tomorrow, November 17th, provided that a period of six months has elapsed since the completion of their vaccination scheme (namely the administration of a second dose in the case of Pfizer/BioNTech, Moderna and AstraZeneca vaccines or Johnson & Johnsons []

Boosters will be made available to all those aged 40 and above on Wednesday, provided that six months have elapsed since the previous shot, the health ministry said. Pfizer and Moderna boosters, third jabs, will be made available to all those who received the mRNA vaccines previously, as well as

According to a report by the People’s Vaccine Alliance, In contrast, AstraZeneca and Johnson & Johnson sell their vaccines at a cost price.

Germany, France, Denmark, Norway, Sweden, and Finland have all suspended the Moderna vax for people under 30. But in the US discussions about myocarditis are still being censored and Moderna

Related Stocks: MRNA , FTSM , PLTR , COST , BX , AAPL , VO , BABA , VB , NUV , VOO ,

Equities analysts expect that Moderna, Inc. (NASDAQ:MRNA) will report sales of $6.10 billion for the current fiscal quarter, according to Zacks. Six analysts have made estimates for Modernas earnings. The lowest sales estimate is $4.11 billion and the highest is $7.08 billion. Moderna posted sales of $570.75 million during the same quarter last year, which []

New Yorkers who got a Moderna or Pfizer dose at least six months ago or the Johnson & Johnson vaccine at least two months ago are eligible To view the full story, click the title link.